Venmo Rival Zelle Enlists "Hamilton" Star for Ad Campaign
Venmo rival Zelle shakes traditional advertising up by enlisting Hamilton star Daveed Diggs for its latest ad campaign. They've teamed up with the actor to launch the TV commercials on the biggest stages, including the NFL playoffs. Daveed Diggs joined us on Cheddar to share why he thought the payments company chose him as an ambassador for the brand.
Diggs said his project with Zelle was a rare opportunity for an artists because the company gave him so much creative control over the advertisement. While the process was collaborative, he explains that he had a lot of say in the writing of the lyrics for the raps used in the ads. The Hamilton star expresses that he thinks Zelle is intentionally trying to make sure people know the app is for everyone.
We also discussed the next big projects in Diggs' pipeline. He said he has a film that he has been writing for the last decade going to the Sundance Film Festival. When asked whether he'd return to broadway, Diggs said he would like to continue performing in theater, but broadway is not particularly important to him.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
